Public Affairs Strategy as a Necessity for the Pharmaceutical Industry
Recent developments in the global pharmaceutical market demonstrate that lobbying and public affairs strategies are increasingly becoming critical “weapons” for companies. With the ongoing bargaining between pharmaceutical manufacturers and the U.S. under Trump unsettling international markets, it is clear that companies no longer rely solely on innovative products or local market access strategies; they are…